Santen's fundamental disclosure policy is to provide our shareholders and investors with information concerning our management policies, business strategies and financial performance in a coherent, fair and accurate manner. In this context, we disclose our corporate information in accordance with the Timely Disclosure Rules set by the Tokyo Stock Exchange and the Osaka Securities Exchange where our stocks are listed.
Santen will disclose, in a timely and appropriate manner, any new information related to decisions, events, financial accounting or other matters that may significantly affect investments in securities; any inquiries lodged by the Tokyo Stock Exchange or the Osaka Securities Exchange; and any important changes or repeals made to corporate information already released. Although information to be disclosed may concern pharmaceuticals or newly developed drugs, such information will not be intended for any promotion or medical advice.
Information disclosed is subject to addition, change or deletion without notice.
Santen will disclose corporate information via the Tokyo Stock Exchange Timely Disclosure Network (TDnet) and other means in accordance with the Timely Disclosure Rules.
Information released through TDnet and other means will also be posted on our corporate website for the sake of timeliness and fairness.
Furthermore, under our policy of timely disclosure Santen will endeavor to release information concerning matters beyond the scope of the Timely Disclosure Rules in an appropriate, accurate, fair and expeditious manner.
Santen may provide financial forecasts through means beyond those required by the stock exchanges where our shares are listed.
Information on business plans, forecasts and strategies may be included in news releases, company-issued documentation, website contents, meetings on financial results and analyst meetings.
However, such information would have been chosen from data available at the time when the Santen management team made practical determinations for disclosure, and therefore may entail arbitrary degrees of risk and uncertainty.
As such, actual results may differ greatly from previous forecasts due to various factors. Please refer to the section on business risk for more details.
Rumors and speculation
Santen's basic policy is to refrain from commenting about market rumors and speculation. However, we will take appropriate and timely action if we conclude that such rumors and speculation will severely affect our ability to operate in the market or if stock exchanges or other agencies ask us to provide explanations.
To ensure fairness and to prevent leaks of important corporate information such as that pertaining to financial performance, Santen has designated a quiet period that starts on the day immediately following the closing day of each quarter and ends on the day of the release of the financial results of that quarter. Santen will refrain from providing comments or answering inquiries about our financial performance during this period. However, we will release information about any events within the scope our timely disclosure policy that may arise during the quiet period. The terms of this quiet period do not apply to inquiries regarding information already released.
Established on Apr 01, 2013